249 related articles for article (PubMed ID: 1387127)
1. In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin.
Iigo M; Nishikata K; Hoshi A
Jpn J Cancer Res; 1992 Apr; 83(4):392-6. PubMed ID: 1387127
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of 2,2'-anhydro-5-ethyluridine, a uridine phosphorylase inhibitor, on the antitumor activity of 5-fluorouridine and 5-fluoro-2'-deoxyuridine.
Iigo M; Nishikata K; Nakajima Y; Szinai I; Veres Z; Szabolcs A; De Clercq E
Biochem Pharmacol; 1990 Apr; 39(7):1247-53. PubMed ID: 2138895
[TBL] [Abstract][Full Text] [Related]
3. Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition.
Sinnige HA; Timmer-Bosscha H; Peters GF; De Vries EG; Mulder NH
Anticancer Res; 1993; 13(5A):1335-40. PubMed ID: 8239504
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human interferon alpha-2a increases 5-fluorouracil efficacy by elevating fluorouridine concentration in tumor tissue.
Kase S; Kubota T; Watanabe M; Teramoto T; Kitajima M; Hoffman RM
Anticancer Res; 1994; 14(3A):1155-9. PubMed ID: 8074466
[TBL] [Abstract][Full Text] [Related]
5. The difference in mechanism of action of 5-fluorouracil and its nucleosides in L5178y cells.
Yoshida M; Hoshi A; Kuretani K
J Pharmacobiodyn; 1980 Aug; 3(8):374-9. PubMed ID: 6451683
[TBL] [Abstract][Full Text] [Related]
6. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase.
van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ
Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671
[TBL] [Abstract][Full Text] [Related]
7. Tumor size and origin determine the antitumor activity of cisplatin or 5-fluorouracil and its modulation by leucovorin in murine colon carcinomas.
Van Laar JA; Rustum YM; Van der Wilt CL; Smid K; Kuiper CM; Pinedo HM; Peters GJ
Cancer Chemother Pharmacol; 1996; 39(1-2):79-89. PubMed ID: 8995503
[TBL] [Abstract][Full Text] [Related]
8. Irreversible cytotoxic effect of a novel lowly immunosuppressive antitumor fluorouridine derivative, UK-21.
Mori H; Nakayama K; Ishida R; Ito S; Nagai H; Koda A
Anticancer Drugs; 1997 Jun; 8(5):482-8. PubMed ID: 9215612
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 5-fluoro-2'-deoxyuridine and 5-fluorouracil in the treatment of murine colon cancer; effects on thymidylate synthase.
van der Wilt CL; van Laar JA; Smid K; Rustum YM; Peters GJ
Adv Exp Med Biol; 1994; 370():109-14. PubMed ID: 7660870
[No Abstract] [Full Text] [Related]
10. Antitumor effect and tumor level of 5-fluoro-2'-deoxyuridylate following oral administration of tetradecyl 2'-deoxy-5-fluoro-5'-uridylate.
Nakajima Y; Iigo M; Hoshi A
Anticancer Drugs; 1992 Jun; 3(3):289-92. PubMed ID: 1525410
[TBL] [Abstract][Full Text] [Related]
11. Dual modulation by l-leucovorin and recombinant human interferon alpha 2a of 5-fluorouracil antitumor activity against the human colon carcinoma xenograft Co-4.
Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Kuo TH; Saikawa Y; Teramoto T; Kitajima M
J Interferon Cytokine Res; 1995 Dec; 15(12):1089-93. PubMed ID: 8746791
[TBL] [Abstract][Full Text] [Related]
12. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
Lorenz M; Müller HH
J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236
[TBL] [Abstract][Full Text] [Related]
13. The modulation by L-leucovorin of 5-fluorouracil antitumor activity on human colon carcinoma cells in vitro and in vivo.
Kase S; Kubota T; Watanabe M; Takahara T; Takeuchi T; Yamaguchi H; Furukawa T; Teramoto T; Kodaira S; Ishibiki K
Surg Today; 1993; 23(7):615-20. PubMed ID: 8369613
[TBL] [Abstract][Full Text] [Related]
14. Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.
Peters GJ; Braakhuis BJ; de Bruijn EA; Laurensse EJ; van Walsum M; Pinedo HM
Br J Cancer; 1989 Mar; 59(3):327-34. PubMed ID: 2522792
[TBL] [Abstract][Full Text] [Related]
15. Biochemical modulation of 5-fluorouracil with leucovorin or delayed uridine rescue. Correlation of antitumor activity with dosage and FUra incorporation into RNA.
Nord LD; Stolfi RL; Martin DS
Biochem Pharmacol; 1992 Jun; 43(12):2543-9. PubMed ID: 1378737
[TBL] [Abstract][Full Text] [Related]
16. 5-Fluorouracil and derivatives in cancer chemotherapy. 3. In vivo enhancement of antitumor activity of 5-fluorouracil (FU) and 5-fluoro-2'-deoxyuridine (FUDR).
Jato J; Windheuser JJ
J Pharm Sci; 1973 Dec; 62(12):1975-8. PubMed ID: 4271579
[No Abstract] [Full Text] [Related]
17. Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model.
van Laar JA; van der Wilt CL; Rustum YM; Noordhuis P; Smid K; Pinedo HM; Peters GJ
Clin Cancer Res; 1996 Aug; 2(8):1327-33. PubMed ID: 9816304
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human lung cancer cell lines.
Tsai CM; Gazdar AF; Allegra C; Perng RP; Kramer BS
Int J Cancer; 1990 Jul; 46(1):101-5. PubMed ID: 2163987
[TBL] [Abstract][Full Text] [Related]
19. Effects of oxaliplatin and CPT-11 on cytotoxicity and nucleic acid incorporation of the fluoropyrimidines.
Patel M; Agarwal R; Ardalan B
J Cancer Res Clin Oncol; 2004 Aug; 130(8):453-9. PubMed ID: 15205948
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic conversion of 5-fluoro-2'-deoxyuridine to 5-fluorouracil or 5-fluoro-2'-deoxyuridine 5'-monophosphate in human tissues.
Uchida M; Brown N; Ho DH
Anticancer Res; 1990; 10(3):779-83. PubMed ID: 2142396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
